A novel vaccine for cervical cancer: quadrivalent human papillomavirus (types 6, 11, 16 and 18) recombinant vaccine (Gardasil®)

VA Govan - Therapeutics and clinical risk management, 2008 - Taylor & Francis
Human papillomaviruses (HPVs) are one of the most common sexually transmitted
infections and remains a public health problem worldwide. There is strong evidence that …

Quadrivalent human papillomavirus recombinant vaccine: The fi rst vaccine for cervical cancers

R Sharma, CL Sharma - Journal of Cancer Research and …, 2007 - journals.lww.com
Gardasil® is the first quadrivalent human papillomavirus (HPV)–types 6, 11, 16, 18
recombinant vaccine approved by the FDA on June 8, 2006. It induces genotype-specific …

Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®) A review of its Use in the Prevention of Premalignant Genital Lesions …

PL McCormack, EA Joura - Drugs, 2010 - Springer
Quadrivalent human papilloma virus (HPV)[types 6, 11, 16, 18] recombinant vaccine
(Gardasil®; Silgard®) is composed of virus-like particles (VLPs) formed by self-assembly of …

Expanded strain coverage for a highly successful public health tool: Prophylactic 9-valent human papillomavirus vaccine

Z Zhang, J Zhang, N Xia, Q Zhao - Human vaccines & …, 2017 - Taylor & Francis
Human papillomavirus is considered the causative factor for cervical cancer, which accounts
for approximately 5% of the global cancer burden and more than 600,000 new cases …

Spotlight on quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine (Gardasil®) in the prevention of premalignant genital lesions, genital cancer …

PL McCormack, EA Joura - BioDrugs, 2011 - Springer
Quadrivalent human papilloma virus (HPV)[types 6, 11, 16, 18] recombinant vaccine
(Gardasil®; Silgard®) is composed of virus-like particles (VLPs) formed by self-assembly of …

Developing an HPV vaccine to prevent cervical cancer and genital warts

JT Bryan - Vaccine, 2007 - Elsevier
The challenges of the journey from target identification through development of a
prophylactic quadrivalent human papillomavirus (HPV) vaccine have been met in Gardasil® …

Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®): A Review of Its Use in the Prevention of Premalignant Anogenital …

PL McCormack - Drugs, 2014 - Springer
Quadrivalent human papillomavirus (HPV)[types 6, 11, 16, 18] recombinant vaccine
(Gardasil®; Silgard®) is composed of virus-like particles formed by self-assembly of …

Safety and efficacy data on vaccines and immunization to human papillomavirus

N Kash, MA Lee, R Kollipara, C Downing… - Journal of clinical …, 2015 - mdpi.com
Since the discovery of the causal association between human papillomavirus (HPV) and
cervical cancer, efforts to develop an effective prophylactic vaccine to prevent high-risk HPV …

Ten years of HPV vaccines: State of art and controversies

R Angioli, S Lopez, A Aloisi, C Terranova… - Critical reviews in …, 2016 - Elsevier
The human papillomavirus (HPV) represents one of the most common sexually transmitted
infections and it has been related to cervical cancer. The HPV vaccines prevent infection …

HPV vaccination with Gardasil®: a breakthrough in women's health

E Hanna, G Bachmann - Expert opinion on biological therapy, 2006 - Taylor & Francis
Human papillomavirus (HPV) represents one of the most common sexually transmitted
infections. Although infection is often self-limited, a percentage of women with HPV infection …